A Phase I Clinical Trial Assessing the Safety, Pharmacokinetics, Pharmacodynamics, and Disintegration Time of Vaginal Tablets Containing Tenofovir and/or Emtricitabine
Phase of Trial: Phase I
Latest Information Update: 06 Apr 2015
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Emtricitabine; Tenofovir disoproxil fumarate
- Indications Hepatitis B; HIV infections
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 31 Aug 2018 Biomarkers information updated
- 31 Mar 2015 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 11 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.